Conversely, spontaneous tumor development in genetically engineered mouse models of prostate cancer and B cell lymphomas are accelerated in NKG2D-deficient mice [11], reflecting the critical role of the NKG2D pathway in cancer immunosurveillance. The gene discussed is KLRK1; the disease is cancer.